Marc L. Humbert
Expertise in
42
conditions

Marc L. Humbert

Paris, FR 
Expertise in
42
conditions
Paris, FR 

Overview

Marc Humbert practices practicing medicine in Paris, France.

Mr. Humbert is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Hypertension, Eosinophilic Asthma, Lung Transplant, and Embolectomy.

He is actively involved in clinical research, co-authoring 878 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Paris, France
Other Locations
Le Kremlin Bicêtre, France
Saclay, France
Le Plessis, France
Raray, France
Marie, France
Department Of Otorhinolaryngology Head And Neck Surgery, UNICAEN, CHU De Caen Normandie, Caen, France
Orsay, France
Toulouse, France
78 Rue Du Général Leclerc, Le Kremlin Bicêtre, Rouez, 94270, France
Chatenay-malabry, 92290, France
Creteil, France
Boulevard Jules Leclercq, Lille, 59037, France
Clamart, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multi-center, Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Compare Cessation Versus Continuation of Long-term Mepolizumab Treatment in Patients With Severe Eosinophilic Asthma (201810)
A Multi-center, Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Compare Cessation Versus Continuation of Long-term Mepolizumab Treatment in Patients With Severe Eosinophilic Asthma (201810)
Enrollment Status: Completed
Publish Date: February 05, 2020
Intervention Type: Drug, Biological
Study Phase: Phase 3

878 Total Publications

Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension.
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension.
Journal: Science translational medicine
Published: May 20, 2026

Frequently Asked Questions about Marc L. Humbert

Is Marc L. Humbert a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Marc L. Humbert is classified as an Elite expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marc L. Humbert participate in research or clinical trials?

Yes. Marc L. Humbert has published 878 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Marc L. Humbert's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Humbert's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 32 Advanced Conditions
View All 94 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile